Current Report Filing (8-k)
20 December 2021 - 10:04PM
Edgar (US Regulatory)
0001779020
false
0001779020
2021-12-15
2021-12-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
United States
Securities and Exchange Commission
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): December
15, 2021
DANIMER SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-39280
|
|
84-1924518
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification Number)
|
140 Industrial Boulevard
Bainbridge, Georgia
|
|
39817
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area
code: (229) 243-7075
N/A
(Former name or former address, if changed since last
report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
☐
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
☐
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
☐
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
|
☒
|
Emerging growth company
|
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Class A Common stock, $0.0001 par value per share
|
|
DNMR
|
|
The New York Stock Exchange
|
Item 5.07 Submission of Matters to a Vote of Security Holders.
On December 15, 2021, Danimer Scientific, Inc. (the
“Company”) held an Annual Meeting of Stockholders. Of the 100,344,315 shares of common stock outstanding and entitled to vote
at the Meeting, 71,402,617 shares of common stock were present in person or by proxy and entitled to vote, representing approximately
71.16% of the Company’s shares of common stock entitled to vote at the Meeting.
At the Meeting, the Company’s
stockholders: (i) approved the election of each of the following eight director nominees standing for election: Stephen E. Croskrey, John
P. Amboian, Richard Hendrix, Christy Basco, Philip Gregory Calhoun, Gregory Hunt, Dr. Isao Noda, and Stuart W. Pratt, and (ii) ratified
the appointment of KMPG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021.
The voting results for each proposal are set forth
below:
Proposal 1 – To elect eight members to serve
on the Company’s Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and
qualified:
Name
|
Votes For
|
Votes Withheld
|
Broker
Non-Votes
|
Stephen E. Croskrey
|
46,366,372
|
3,717,736
|
21,318,509
|
John P. Amboian
|
37,381,382
|
12,702,726
|
21,318,509
|
Richard Hendrix
|
38,938,557
|
11,145,551
|
21,318,509
|
Christy Basco
|
49,531,279
|
552,829
|
21,318,509
|
Philip Gregory Calhoun
|
42,776,988
|
7,307,120
|
21,318,509
|
Gregory Hunt
|
46,478,525
|
3,605,583
|
21,318,509
|
Dr. Isao Noda
|
42,946,722
|
7,137,386
|
21,318,509
|
Stuart W. Pratt
|
46,240,764
|
3,843,344
|
21,318,509
|
Proposal 2 – To ratify the appointment of
KMPG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021:
Votes
For
|
Votes
Against
|
Votes
Abstained
|
Broker
Non-Votes
|
71,226,526
|
81,365
|
94,726
|
0
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 17, 2021
|
DANIMER SCIENTIFIC, INC.
|
|
|
|
|
By:
|
/s/ John A. Dowdy, III
|
|
Name:
|
John A. Dowdy, III
|
|
Title:
|
Chief Financial Officer
|
Live Oak Acquisition (NYSE:LOAK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Live Oak Acquisition (NYSE:LOAK)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Live Oak Acquisition Corp (New York Stock Exchange): 0 recent articles
More Danimer Scientific, Inc. News Articles